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Abstract
Background: The hemorrhagic shock and encephalopathy syndrome (HSES) is a devastating
disease that affects young children. The outcomes of HSES patients are often fatal or manifesting
severe neurological sequelae. We reviewed the markers for an early diagnosis of HSES.
Methods: We examined the clinical, biological and radiological findings of 8 patients (4 months to
9 years old) who met the HSES criteria.
Results: Although cerebral edema, disseminated intravascular coagulopathy (DIC), and multiple
organ failure were seen in all 8 cases during their clinical courses, brain computed tomography (CT)
scans showed normal or only slight edema in 5 patients upon admission. All 8 patients had normal
platelet counts, and none were in shock. However, they all had severe metabolic acidosis, which
persisted even after 3 hours (median base excess (BE), -7.6 mmol/L). And at 6 hours after admission
(BE, -5.7 mmol/L) they required mechanical ventilation. Within 12 hours after admission, fluid
resuscitation and vasopressor infusion for hypotension was required. Seven of the patients had
elevated liver enzymes and creatine kinase (CK) upon admission. Twenty-four hours after
admission, all 8 patients needed vasopressor infusion to maintain blood pressure.
Conclusion: CT scan, platelet count, hemoglobin level and renal function upon admission are not
useful for an early diagnosis of HSES. However, the elevated liver enzymes and CK upon admission,
hypotension in the early stage after admission with refractory acid-base disturbance to fluid
resuscitation and vasopressor infusion are useful markers for an early HSES diagnosis and helpful
to indicate starting intensive neurological treatment.
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Background
Since the original description of the hemorrhagic shock
and encephalopathy syndrome (HSES) by Levin et al. [1],
numerous cases have been reported in the literature.
Although the etiology of HSES remains unknown, this
syndrome is associated with acute onset of encephalopa-
thy, shock, watery diarrhea, severe disseminated intravas-
cular coagulopathy (DIC), and renal and hepatic
dysfunction.
As some authors have defined the HSES criteria [2-4],
patients meeting them will usually have very poor prog-
noses with a fatal course or severe neurological sequelae.
Our experience suggests that early detection of HSES plays
an important role in survival and the reduction of neuro-
logical sequelae.
Patients and methods
We described the clinical courses of 8 patients (age range,
4 months to 9 years) who met the HSES criteria of Bacon
et al. [3], were admitted to our Intensive Care Unit
between November 2001 and August 2007, and whose
patient records were reviewed to detect markers for an
early diagnosis of HSES.
Patients were excluded if they had an elevated plasma
ammonium concentration (>130 μmol/l), historic evi-
dence of Reye's syndrome, inadvertent heating, features of
the staphylococcal toxic shock syndrome and/or the
hemolytic-uremic syndrome, or if any recognized bacte-
rial pathogens or metabolic disorders were discovered
that would explain the illness.
Status epilepticus was defined as an epileptic seizure or
seizures lasting more than 30 minutes or recurring within
30 minutes without recovery of consciousness. The bio-
logical investigations performed for all 8 patients
included white blood cell (WBC) counts, C-reactive pro-
tein (CRP), platelet counts, hemoglobin, asparate ami-
notransferase (AST), and alanine aminotransferase (ALT),
creatinine, base excess, creatine kinase (CK), and cell
counts of cerebrospinal fluid (CSF). Serum lactate level
was measured in 6 patients. DIC was defined as a
decreased platelet count and an increase in fibrinogen/
fibrin degradation production. Metabolic acidosis was
defined as base excess (BE) lower than -3 mmol/L.
Lumbar puncture (LP) was performed upon admission for
all patients except one whose LP was performed at the pre-
vious hospital and could not be performed at our center
because of the CT findings of moderate cerebral edema.
Specimens of blood, urine, stool, sputum, and CSF of all
8 patients were obtained to determine any bacterial and/
or viral agents as soon as possible after admission.
Computer tomography (CT) was performed upon admis-
sion, electroencephalogram (EEG) was done within 3
hours of admission, and CT was repeated for each patient
the following day.
All 8 patients needed mechanical ventilation due to coma
and/or seizure. After admission, they required continuous
diazepam or barbiturate infusion for seizure or brain
edema with the head of the bed elevated 30°.
When hypotension was recognized, fluid resuscitation
with a crystalloid or colloid and norepinephrine infusion
was set up. The fluid resuscitation target was a central
venous pressure (CVP) of ≥ 8 mmHg, urine output >1 ml/
kg/hr. Norepinephrine infusion was started when hypo-
tension was refractory with fluid resuscitation. After these
cultures were obtained, all the patients took broad-spec-
trum antibiotics until their bacterial infections were
resolved.
The changes of base excess and serum lactate levels were
expressed as mean ± SD. When a median was used, the
range was given.
The Osaka City General Hospital ethics committee
approved this retrospective analysis of patients' data and
informed consent was obtained from the patients' next of
kin.
Results
All 8 patients were admitted comatose or with febrile con-
vulsions. Five patients had a history of diarrhea and/or
vomiting. The patients' ages ranged from 4 months to 9
years old (median, 1.6 years). Six patients had normal
neurological development, however, 2 patients had previ-
ously been diagnosed as epileptic. Four patients were
admitted in winter, between December and February.
Seven patients were transferred to our center within 24
hours after the onset of coma or convulsions. Three
patients survived (Table 1).
All 8 patients had normal platelet counts, blood pressure
and a normal or slightly elevated CRP level; 7 patients had
a normal hemoglobin level and renal function. All 8
patients had metabolic acidosis and abnormal serum lac-
tate levels. Seven patients had slightly or significantly ele-
vated liver enzymes, CK, and abnormal WBC counts.
Bacterial cultures of blood and CSF were negative for all
the patients, however, viral pathogens were detected by
PCR in 4 patients (Tables 2, 3).
Although abnormal cerebral edema was seen in all the
patients during their clinical courses, 5 patients appeared
normal or only slightly edematous as revealed on their
brain CT scans upon admission. On the initial EEG, multi-BMC Pediatrics 2008, 8:43 http://www.biomedcentral.com/1471-2431/8/43
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focal paroxysmal discharges were seen in 4 patients, and
low-amplitude patterns were seen in 4 other patients. The
CSF cell counts were within a normal range in 7 patients,
while the serum level of IL-6 and soluble IL-2 receptors
increased with varying ranges in all the patients (Table 4).
All 8 patients had hemodynamic failure within 24 hours
after being admitted; therefore, fluids were infused to
maintain arterial pressure with the range of fluid balance
from -6 to 275 ml/kg (median, 61 ml/kg) for 24 hours
from admission for hypotension. Norepinephrine was
given to all patients ranging from 0.1 to 0.5 μg/kg/min
(median, 0.3 μg/kg/min). Twenty-four hours after admis-
sion, 6 patients had normal renal function, and 4 patients
had normal platelet counts. However, 5 patients exhibited
a decrease in hemoglobin (Table 5).
All the patients exhibited a severe metabolic acidosis with
the BE range from -16.0 to -4.4 mmol/L (median, -10.3
mmol/L) upon admission. The acid-base disturbances
were maintained with the BE range from -14.4 to -4.1
mmol/L (median, -7.6 mmol/L) at 3 hours, and from -
15.2 to -3.1 mmol/L (median, -4.7 mmol/L) at 12 hours
after admission with infusion of fluids and/or norepine-
phrine. The metabolic acidosis was refractory to intensive
treatment with mechanical ventilation, infusion of fluids
and/or norepinephrine at 24 hours with the BE range
from -8.3 to -3.1 mmol/L (median, -4.9 mmol/L; Figure
1). Sodium bicarbonate for metabolic acidosis was not
administered because the blood pH was kept in the nor-
mal range (7.35–7.45) with effective ventilation.
Similarly, there was a tendency to maintain the elevated
serum lactate levels, which were measured in 6 patients,
with the range from 2.2 to 11.5 mmol/L (median, 4.2
mmol/L) upon admission, from 2.3 to 11.8 mmol/L
(median, 6.0 mmol/L) at 12 hours after admission, and
from 2.1 to 10.8 mmol/L (median, 6.2 mmol/L) at 24
hours after admission.
CT scan revealed abnormalities between 24 and 72 hours
after onset of coma or seizures (Figure 2). When the CT
revealed bilateral cortical and subcortical areas of low
density, those patients had DIC, anemia and multiple
organ failure. Nevertheless, the respiratory function was
maintained during the clinical course of all patients.
We started intracranial pressure (ICP) monitoring (REF
110-4BT, Camino, USA) in Cases 1 and 2. In Case 1 the
ICP monitoring was started from when the abnormal CT
finding was discovered; however, in Case 2, it was started
immediately after admission, i.e., before an abnormal CT
Table 1: Clinical features and outcomes in HSES patients
Case No. Age yr.mo M/F BT°C History First Sx Neurological status* Etiology Outcome
1 9.0 M 41.2 Epilepsy Pyrexia Seizure Unknown Died
2 1.4 M 39.4 Healthy Pyrexia Comatose Influenza v MS
3 6.4 F 40.0 Epilepsy Pyrexia Seizure Unknown Died
4 1.5 F 40.9 Healthy Diarrhea Comatose Unknown SS
5 1.1 M 39.9 Healthy Vomiting Comatose Norovirus Died
6 1.8 F 40.0 Healthy Vomiting Comatose Rotavirus Died
7 0.6 M 42.0 Healthy Vomiting Comatose Adv type 3 Died
8 0.4 F 39.7 LBW Pyrexia Seizure Unknown SS
Yr, year; mo, month; M, male; F, female; BT, body temperature*; LBW, low birth weight; Sx, symptom; MS; Moderate sequelae; SS, Severe sequelae; 
v, virus; Adv, adenovirus *Upon admission
Table 2: Laboratory values upon admission 1
Case No. Platelet 
104/ul 
(15.0 – 45.0)*
Hb 
g/dl 
(11.0 – 14.0)*
AST/ALT 
IU/L 
(8–38/4 – 44)*
Creatinine 
μmol/L 
(20 – 110)*
Base excess 
mmol/L 
(-3 – +3)*
Lactate 
mmol/L 
(0.3 – 1.7)*
1 16.5 11.6 109/49 137 -12.7 6.2
2 18.1 10.4 104/27 21 -5.2 --
3 17.4 12.9 122/35 40 -14.2 4.2
4 28.5 12.6 68/14 124 -9.6 --
5 23.5 13.1 204/140 62 -4.4 3.4
6 42.7 11.6 59/31 53 -10.9 11.5
7 21.2 12.5 406/48 84 -16.0 4.2
8 41.1 11.9 207/54 80 -8.5 2.2
Hb, hemoglobin; AST, aspartate aminotransferase;
ALT, alanine aminotransferase; *normal valueBMC Pediatrics 2008, 8:43 http://www.biomedcentral.com/1471-2431/8/43
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finding. The ICP was controlled with whole-body hypo-
thermia (34° – 34.5°C) with barbiturate infusion and
osmolar diuretics. When the ICP had increased to over 30
mmHg against all our efforts, we increased the rate of
norepinephrine infusion to maintain the cerebral per-
fusion pressure (CPP). However, it was difficult to control
the ICP and CPP in both of these cases. The maximum ICP
was 109 and 59 mmHg in Cases 1 and 2, respectively (Fig-
ure 3). Patient 1 died on hospital day 24; however, patient
2 improved and was transferred to the pediatric ward on
hospital day 15 as the only patient with moderate seque-
lae among all 8 patients.
Discussion
In 1983, Levin et al. described a devastating disease occur-
ring in early childhood called the hemorrhagic shock and
encephalopathy syndrome [1]. HSES is not a common
disease. Sofer et al. reported 20 patients diagnosed with
HSES in a population of about 400,000 over an 11-year
period [5]. Our center at Osaka City General Hospital is
one of two tertiary pediatric centers in Osaka prefecture.
The area our center services for primary referrals has a
population of about 4 million residents. However, we do
not in any way hypothesize that the 8 patients in our 6-
year study were the only cases of HSES in this large region,
as compared with the 20 patients in the 11-year Sofer et al.
report of a significantly smaller population [5], as there
were most likely other HSES patients who could not be
transferred to our center from other hospitals due to the
rapid deterioration of their conditions. Most reported
cases of HSES occurred in winter [3,5]; as in the present
study, further supporting this evidence, 50% of our
patients were admitted in winter, between December and
February.
The outcome of HSES was often fatal or with severe neu-
rological sequelae [2-6]. In the present study, 5 patients
died, and the 3 survivors had neurological sequelae. The
HSES criteria have been defined in previous reports [2-4].
The clinical presentation includes shock, coma and/or sei-
zure, hemorrhage, diarrhea, and oliguria. Laboratory
investigations reveal decreased hemoglobin and platelet
counts, evidence of DIC, elevated creatinine, AST and ALT,
and metabolic acidosis. However, when patients met the
HSES criteria, their condition was always critical with
multiple organ failure. We determined that these HSES
Table 3: Laboratory values upon admission 2
Case No. WBC 
103/ul 
(5.0 – 14.0)*
CRP 
mg/dl 
(< 0.5)*
Shock 
SBP <70 mmHg
CK 
IU/L 
(55 – 250)*
1 2.8 0.2 - 202
2 9.3 2.0 - 2453
31 7 . 1 0 . 1 - 5 2
4 37.6 0.3 - 907
52 0 . 5 1 . 9 - 1 2 4 1
63 8 . 2 0 . 4 - 1 0 7 0
72 3 . 1 1 . 5 - 1 1 4 4
8 16.4 0.2 - 721
WBC, white blood cell; CRP, C-reactive protein; CK; creatine kinase
SBP, systolic blood pressure; *normal value
Table 4: CT, EEG features, CSF cell counts and IL levels upon admission
Case No. Initial CT findings Initial EEG features CSF 
cell counts/μl 
(< 6)*
IL-6 
pg/ml 
(< 2.6)*
Soluble 
IL-2 R U/ml 
(122 – 466)*
1 Slight cerebral edema MPS 2 2190 2540
2 Slight cerebral edema MPS 1 6.5 2220
3 Slight cerebral edema MPS 3 3780 1950
4 Normal MPS 6 103 827
5 Severe cerebral edema Low amplitude 3# -- --
6 Moderate cerebral edema Low amplitude 5 75.4 3320
7 Normal Low amplitude 3 5344 3360
8 Normal Low amplitude 5 - 1030
CT, computer tomography; EEG, electroencephalogram; CSF, cerebrospinal fluid; IL, interleukin; R, receptor; MPS, multifocal paroxysmal 
discharges
#Performed at a previous hospital; *normal valuesBMC Pediatrics 2008, 8:43 http://www.biomedcentral.com/1471-2431/8/43
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criteria were not useful to help develop an adequate treat-
ment for patients with HSES.
In these cases, the first problem the physician is faced with
is the difficulty of the differential diagnosis. Some reports
have indicated in the differential diagnosis the diseases of
the toxic shock syndrome, the hemolytic-uremic syn-
drome, and Reye's syndrome, among others [6-8]. In our
patients, those diseases were excluded because of the lack
of skin or mucosal manifestations, hemolysis, and/or
blood ammonia levels. The clinical course of our patients
was not indicative of any of these diseases. Heatstroke has
similar clinical and pathological features to HSES; how-
ever, there was no history of over wrapping or excessive
heating in any of our patients in the present study.
The most common first symptoms were seizure or coma
following fever in our cases. From our experience, we have
found that common febrile convulsion is often the most
difficult disease in the differential diagnosis of HSES in
the early stage. Concerning febrile convulsions: prolonged
seizures lasting 5 to 10 minutes are relatively common,
the laboratory data including CSF is near normal, CT
scans reveal normal or slightly edematous conditions, and
elevation of CK levels and WBC counts are often seen in
cases with prolonged seizures [9-12]. Even though follow-
up CT scans could provide useful information about cere-
bral edema [13-15], our results showed that the initial CT
finding was not useful in making the HSES diagnosis.
When an abnormality on the CT was discovered, the
patient's condition was critical.
Harden et al. have reported the importance of EEG fea-
tures and evolution [16], as confirmed by the observa-
tions in the present study, the initial EEG features
appeared abnormal in all patients. However, in the initial
EEG features, it is usually difficult to distinguish HSES
from other diseases with convulsions including febrile
convulsions. Rosman has reported that the initial EEG fea-
tures in patients with febrile convulsions are abnormal in
as many as 88% of the patients [17].
Dunn reported that the outcome of the status epilepticus
was not associated with acidosis on admission [9].
Imuekemhe et al. reported that mean serum lactate on
admission was significantly higher in patients with pro-
longed febrile convulsions compared to the correspond-
ing mean value in patients with only brief convulsions
[18]. Conversely, Levin et al. noticed metabolic acidosis in
HSES patients upon admission [2]. Ince et al. also
reported that metabolic acidosis was the common labora-
tory value in HSES patients upon admission [15]. Little et
al. reported a marked metabolic acidosis being refractory
to fluid-resuscitate in HSES patients [6]. And Idro et al.
reported that the level of base excess of < -8 mmol/l was a
prodromal risk factor for death among children with acute
seizures [19].
In the present study, deterioration of the patients' condi-
tions, especially hemodynamic failure, was dramatic up to
Table 5: Laboratory values 24 hours after admission and hemodynamic therapy
Case No.N.V. Platelet 
(104/ul) 
(15.0–45.0)
Hb 
(g/dl) 
(11.0–14.0)
AST/ALT 
(IU/l) 
(8–38/4–44)
Creatinine 
(μmol/L) 
(20–110)
BE 
(mmol/l) 
(-3–+3)
Lactate 
(mmol/L) 
(0.3–1.7)
FB 
(ml/kg/24 h)
NE 
(μg/kg/min)
1 15.2 12.0 293/162 192 -6.5 6.6 77 0.1
2 24.0 9.8 130/39 20 -4.2 -- 0 0.1
3 1.6 8.4 550/62 90 -7.2 5.8 275 0.5
4 9.4 12.2 198/36 133 -5.1 -- 66 0.5
5 18.1 10.7 58/42 19 -3.1 2.1 56 0.5
6 33.7 10.0 65/40 37 -4.6 10.8 -2 0.5
7 4.6 10.0 841/341 75 -8.3 6.8 187 0.1
8 9.5 9.4 233/78 35 -3.8 2.1 -6 0.1
Hb, hemoglobin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BE, base excess; FB, fluid balance; NE, norepinephrine; N.V., 
normal values
Time course of base excess for the first 24 hours after  admission Figure 1
Time course of base excess for the first 24 hours 
after admission.
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24 hours after admission. The most effective treatment for
metabolic acidosis with high levels of serum lactate is the
adequate and timely treatment of fluid resuscitation and
vasopressor [20,21]. All patients needed large amounts of
fluids and/or norepinephrine infusion. The median rate
of fluid administration needed was 61 ml/kg for 24 hours
with the infusion of norepinephrine. However, neither
metabolic acidosis nor abnormal serum lactate improved
in this study.
Sepsis from bacterial infection was excluded by the nega-
tive bacterial cultures and the normal CRP levels. How-
ever, the hemodynamic course of our patients was very
similar to severe septic shock.
The etiology of HSES is still unknown. It has been
reported that cytokine storm may be associated with the
progress of acute encephalopathy including HSES [22-24]
as septic shock, and levels of some cytokines were useful
markers for HSES [25,26]. The serum levels of IL-6 and
soluble IL-2 receptors were increased in our patients, how-
ever, the degree of the increase varied in each patient.
These results suggest that the increase in cytokines may be
associated with HSES. As septic shock is characterized by
severe vascular leakage, this is the reason that large
amounts of fluids and/or norepinephrine infusions were
needed for the patients in this study.
As previously expressed, the respiratory functions of the
HSES patients in the present study were maintained
throughout their clinical courses. This is the most essen-
tial difference between HSES and sepsis in the state of
multiple organ failure. Sepsis-induced acute lung injury
(ALI)/acute respiratory distress syndrome (ARDS) has
been reported [27], and the inflammatory response in
ALI/ARDS is associated with the release of cytokines [28].
A limitation of the present study was its small population
of only 8 children. Therefore, we did not find a definitive
reason the cytokine storm with HSES did not have a sig-
The changes of CT findings at the level of the basal ganglia of Case 1 Figure 2
The changes of CT findings at the level of the basal ganglia of Case 1. A: CT scan on admission showing slight edema 
without loss of gray or white matter differentiation. B: CT scan 24 hours after admission showing definite basal cistern and cer-
ebral sulci. C: CT scan 48 hours later showing severe edema with vanishing basal cisternae and loss of gray and white matter 
differentiation.
AB C
Time course of ICP in Cases 1 and 2 after admission Figure 3
Time course of ICP in Cases 1 and 2 after admission. 
ICP control was difficult when monitoring was started after 
the abnormal CT finding was discovered in Case 1, therefore, 
the maximum ICP was increased to 109 mmHg. ICP moni-
toring started before the presence of abnormal CT findings 
in Case 2 in which the maximum ICP was increased to 59 
mmHg; however, the CPP could be maintained above 50 
mmHg. This patient was the only case with mild sequelae 
among all our cases.
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nificant influence on the pulmonary vascular permeabil-
ity, as would a prodromal marker of ALI/ARDS. It is our
supposition that this difference is a key point that would
detect the etiology of HSES.
Further studies are warranted to discover what kinds of
cytokines would be the most useful markers. The current
problem that we face in our center is that it takes consid-
erable time and effort to get the necessary results for these
cytokines.
We detected viral pathogens in 4 of 8 patients in the
present study. Viral infection may be the trigger for the
pathogenesis of HSES as reported in the case report by
Gooskens et al. [22]. It may be associated with the most
common season of HSES – winter.
Even though there were abnormalities in coagulation,
hemoglobin, and renal function, they were useful to make
a diagnosis of HSES, it was evident that these laboratory
abnormalities were not appreciated as diagnostic markers
until at least 24 hours after admission [14,29].
Therefore, we did not have sufficient time to make a
proper diagnosis of HSES using the established criteria [2-
4]. A diagnosis of HSES ought to be made within 24 hours
of admission, otherwise the patients' conditions worsen
and the window to provide adequate treatment closes.
The second problem is the treatment of patients with
HSES. Even though prolonged metabolic acidosis and/or
high levels of serum lactate refractory to large amounts of
fluids and/or norepinephrine infusion are useful markers
for an early diagnosis, they are not useful as markers when
only respiration and circulation management is provided.
Because the brain appears to be the main target organ of
HSES, in our non-surviving patients, severe diffuse brain
edema with loss of differentiation between the gray and
white matter was found on the CT scan during the clinical
course. And similar CT abnormalities have been described
in non-surviving patients in other reports [13,15].
The cause of brain edema following HSES remains
unclear, however, Unterberg et al. reported that brain
edema of traumatic brain injury was associated with vari-
ous mediators including cytokines, lactate, free oxygen
radicals, etc. [30]. Brain edema in HSES patients seems to
occur in such a situation. Because the serum levels of
cytokines and lactate had increased, an increase in vascu-
lar permeability was suggested by our patients needing
large amounts of fluids. Furthermore, large amounts of
fluid-resuscitate within 24 hours of admission may lead to
brain edema under the state of increasing vascular perme-
ability.
We propose that for the most efficacious management of
ICP, whenever possible, ICP monitoring ought to be
started before detection and observation of any decrease
in the platelet count and/or any abnormal CT findings
because ICP monitoring could not be performed with
DIC. This is the reason that a diagnosis of HSES should be
made within the early stage, i.e., within 24 hours of
admission.
However, to our knowledge, there have not been any
reports published proposing an effective treatment for
HSES. Controlling brain edema might be the optimal
therapy to help HSES patients survive. Even though there
are currently only palliative therapies, e.g., mild hypother-
mia, infusion of fluids and osmotic diuretics, administra-
tion of anticonvulsants under mild hyperventilation, and
vasoconstrictor infusion to prevent edema and to main-
tain the cerebral perfusion pressure (CPP). There are no
reports about the efficacy of the control of ICP and CPP
upon the outcome of the HSES; however, we suggest that
the control of ICP and CPP is an essential part of any ther-
apeutic treatment.
Conclusion
A patient characterized by coma or seizure following
hyperpyrexia might be diagnosed as having common
febrile convulsions. However, when such a patient also
presents with elevated liver enzymes and CK upon admis-
sion, hypotension within 24 hours after admission, with
refractory acid-base disturbance and an abnormally high
serum lactate level, even with fluid-resuscitate and/or
vasopressor infusion, these signs may be useful markers
for an early HSES diagnosis and indicators to start inten-
sive neurological treatment. HSES is not a disease that can
be diagnosed easily using the current diagnostic criteria,
however, HSES can be predicted in the early stage of its
clinical course using these new prodromal diagnostic
markers.
Key messages
￿ When the patients met the HSES criteria, their condition
was always critical with multiple organ failure.
￿ CT scan, DIC, EEG, or renal function upon admission
did not prove useful for an early diagnosis of HSES.
￿ Elevated liver enzymes and CK upon admission, hemo-
dynamic failure in the early stage after admission, and a
prolonged metabolic acidosis refractory to intensive treat-
ment were useful markers for an early diagnosis of HSES.
￿ Controlling brain edema might be the most important
therapy to help HSES patients survive.BMC Pediatrics 2008, 8:43 http://www.biomedcentral.com/1471-2431/8/43
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￿ HSES is a disease that should be predicted within the
early stage of its clinical course.
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